Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04222517
Other study ID # 1
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 10, 2017
Est. completion date January 4, 2020

Study information

Verified date January 2020
Source Nijznevartovsk County Clinical Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Design of a simple blind randomized controlled trial study. Large incisional hernia repair with use of local hemostatic Hemoblock


Description:

Design of a simple blind randomized controlled trial study. The total number of subjects was 66. In the main group (A) - 33, in the other group (B) - 33. Operation - sublay retromuscular using prolene mesh implant. In group A Hemoblock 15 ml in the retromuscular and 15 ml in the subcutaneous spaces were used. Wounds were drained by vacuum-suction drainage. Postoperative monitoring of early ultrasound examinations on the 3rd, 7th, 10th, 12th, 15th, 18th, 21st, 25th, 28th, 30th days after drainage removal.

In group B were used a standard intervention (sublay retromuscular).


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date January 4, 2020
Est. primary completion date October 15, 2018
Accepts healthy volunteers No
Gender All
Age group 25 Years to 75 Years
Eligibility Inclusion Criteria:

1. ASA I, II, III

2. the absence of oncological pathology

3. consent to participate in the study

4. Large incisional hernia (hernial defect =10 cm in diameter and/or area of hernial defect =100 cm2) according to the classification of EHS, 2009 (W3); age 25-75 years

Exclusion Criteria:

1. age older than 75 years

2. decompensated concomitant pathology, ASA=IV

3. patient refusal to participate in the study

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Incisional hernia repair by the mesh implant in sublay retromusuclar position
Incisional hernia repair using mesh prolene implant in sublay retromuscular position. Dissect the posterior rectus sheets, suture them continuously, formed a retromuscular space in which the standard prolene mesh implant is installed. Perform hemostasis. Install the drainage tube into the retromuscular space. After that, the anterior rectus sheets were sutured, hemostasis was performed, a drainage tube was installed in the subcutaneous tissue. Drainage tubes were connected to the UnoVac vacuum aspiration system (Unomedical, Denmark).
Incisional hernia repair by the mesh implant in sublay retromusuclar position with using a local hemostatic Hemoblock
Incisional hernia repair using mesh prolene implant in sublay retromuscular position. Dissect the posterior rectus sheets, suture them continuously, formed a retromuscular space in which the standard prolene mesh implant is installed. Perform hemostasis. Install the drainage tube into the retromuscular space. Used a local hemostatic Hemoblock 15 ml in this space. After that, the anterior rectus sheets were sutured, hemostasis was performed, a drainage tube was installed in the subcutaneous tissue. Used a local hemostatic Hemoblock 15 ml in subcutaneus space. Drainage tubes were connected to the UnoVac vacuum aspiration system (Unomedical, Denmark).

Locations

Country Name City State
Russian Federation Nijnevartovsk Clinical County Hospital Nijnevartovsk

Sponsors (1)

Lead Sponsor Collaborator
Nijznevartovsk County Clinical Hospital

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary drainage duration Duration of drainage in days from 1 to 6 days after operation
Primary the amount of the exudate from post-op wound How many ml is exudate from the wound from 1 to 6 days after operation
Primary the ultrasound changes of fluid collections in the postoperative wound volume of the fluid collections in the post-op wound after drains removal on the 3rd, 7th, 10th, 12th, 15th, 18th, 21st, 25th, 28th, 30th days after drainage removal.
Primary the number of necessary punctures of the postoperative wound How many punctures need to treatment fluid collections up to 30 days after drains removal
Primary amount of seromas use Morales-Conde classification up to 30 days after drains removal
Primary other postoperative wound complications such as SSI, thromboembolism, therapeutic complications up to 30 days after drains removal
Primary white blood cell count in exudate from post-op wound The number of leukocytes from 1 to 6 days after operation
Primary the number of lymphocytes in exudate from post-op wound The number of lymphocytes from 1 to 6 days after operation
Primary the amount of C-RP in exudate from post-op wound The number of C-RP from 1 to 6 days after operation
Primary the amount of Albuminum in exudate from post-op wound The number of Albuminum from 1 to 6 days after operation
Secondary Lenght of the Hospital stay Days from 4 to 18 days
Secondary post-operative pain scores using numerical rating on Visual Analogue Scale (VAS) Ten days after surgery twice a day (at 06:00 AM and at 06:00 PM). A ten-point scale, where 0 points - no pain and 10 points - unbearable pain Ten days after surgery twice a day (at 06:00 AM and at 06:00 PM).
Secondary The concentration of NSAD in mg of applied analgesics NSAD (Ketoprofen) up to 7-10 days after surgery
Secondary The concentration of Tramadol in mg of applied analgesics Tramadol up to 7-10 days after surgery
Secondary The concentration of Trimeperidine in mg of applied analgesics Trimeperidine up to 7-10 days after surgery
Secondary Duration of use NSAD in days NSAD (Ketoprofen) up to 7-10 days after surgery
Secondary Duration of use Tramadol in days Tramadol up to 7-10 days after surgery
Secondary Duration of use Trimeperidine in days Trimeperidine up to 7-10 days after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT06051578 - Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation
Recruiting NCT04098380 - Small Versus Large Bite Closure of Emergency Midline Laparotomy N/A
Completed NCT02616718 - Incisional Hernia Progression Over Time N/A
Completed NCT06034652 - T-GENVIH-003 LTFU (Long Term Follow Up) Study
Completed NCT00749268 - AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair Phase 4
Not yet recruiting NCT05467124 - Enhanced Recovery After Abdominal Wall Reconstruction
Completed NCT00472537 - ProLOVE - Prospective Randomized Study of Midline Incisional Hernia Treatment N/A
Active, not recruiting NCT02365194 - Modifying Risk in Ventral Hernia Patients N/A
Recruiting NCT04718168 - GORE® ENFORM Biomaterial Product Study N/A
Completed NCT02594241 - PreOperative Steroid in Abdominal Wall Reconstruction: A Double-blinded Randomized Clinical Trial N/A
Active, not recruiting NCT02363790 - Primary Fascial Closure With Laparoscopic Ventral Hernia Repair: A Randomized Controlled Trial N/A
Completed NCT02398565 - Pregnancy Subsequent to Ventral Hernia Repair N/A
Terminated NCT02041494 - Complex Ventral Hernia Repair Using Biologic or Synthetic Mesh N/A
Completed NCT00532870 - Laparoscopic Intraperitoneal Mesh Repair of Ventral Hernia: Comparison to Conventional Mesh Repair N/A
Completed NCT05320055 - Pain and Readmission After Lap IPOM vs. Robotic Ventral Hernia Repair
Completed NCT04229940 - Peritoneal in Laparoscopic Ventral Hernia Repair 2 Phase 2
Completed NCT05446675 - Endoscopic eTEP Versus Open Rives-Stoppa
Completed NCT05912868 - Endoscopic Mini/Less Open Sublay(EMILOS) Repair
Withdrawn NCT04143776 - Renal- and Pulmonary Function in Relation to Abdominal Hypertension After Abdominal Reconstruction
Active, not recruiting NCT02457364 - Non-Op Management of Ventral Hernia Patients